Related Experiment Videos
Basal cell carcinoma: response to systemic chemotherapy for lung carcinoma
D Kaufman1, R Gralla, P L Myskowski
1Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Journal of the American Academy of Dermatology
|February 1, 1988
Abstract:
Two patients had regression of basal cell carcinoma while receiving systemic chemotherapy for carcinoma of the lung. The chemotherapeutic agents with some efficacy in basal cell carcinoma are reviewed. Based on our patients and data from the literature, cisplatin appears to be a drug of potential usefulness in some patients with this neoplasm.